1. Home
  2. WVE vs AVA Comparison

WVE vs AVA Comparison

Compare WVE & AVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.35

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo Avista Corporation

AVA

Avista Corporation

N/A

Current Price

$39.38

Market Cap

3.2B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
AVA
Founded
2012
1889
Country
Singapore
United States
Employees
N/A
1929
Industry
Biotechnology: Pharmaceutical Preparations
Power Generation
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
3.2B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
WVE
AVA
Price
$13.35
$39.38
Analyst Decision
Strong Buy
Hold
Analyst Count
15
3
Target Price
$31.47
$38.67
AVG Volume (30 Days)
2.2M
636.6K
Earning Date
01-01-0001
05-28-2026
Dividend Yield
N/A
5.04%
EPS Growth
N/A
3.93
EPS
N/A
2.38
Revenue
$3,704,000.00
$1,964,000,000.00
Revenue This Year
N/A
$0.20
Revenue Next Year
$119.93
$4.12
P/E Ratio
N/A
$16.36
Revenue Growth
149.43
1.34
52 Week Low
$5.28
$35.50
52 Week High
$21.73
$43.50

Technical Indicators

Market Signals
Indicator
WVE
AVA
Relative Strength Index (RSI) 47.54 40.46
Support Level $12.53 $36.51
Resistance Level $14.56 $41.93
Average True Range (ATR) 0.79 0.82
MACD 0.01 -0.27
Stochastic Oscillator 23.84 14.81

Price Performance

Historical Comparison
WVE
AVA

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About AVA Avista Corporation

Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P segment is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.

Share on Social Networks: